Patents Examined by Abigail Fisher
  • Process for preparing polyurea microcapsules
    Patent number: 9271905
    Abstract: The present invention relates to a process for producing perfume-containing microcapsules with a polyurea wall that can be used in home or personal care products, as well as to the microcapsules themselves and consumer products that contain these microcapsules. The process of the invention uses a combination of aromatic and aliphatic polyisocyanates in specific relative concentrations.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: March 1, 2016
    Assignee: Firmenich S.A.
    Inventors: Arnaud Struillou, Nicolas Pichon, Sonia Godefroy, Claudie Bellouard Drevet
  • Compositions and methods for treating purpura
    Patent number: 9265761
    Abstract: Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an ? adrenergic receptor agonist selected from selective ?1 adrenergic receptor agonist, selective ?2 adrenergic receptor agonist, non-selective ?1/?2 adrenergic receptor agonist, agents with ?2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.
    Type: Grant
    Filed: February 16, 2014
    Date of Patent: February 23, 2016
    Assignee: ALLERGAN, INC.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Three-dimensional bone implant and method for producing same
    Patent number: 9265862
    Abstract: A method for ex vivo production of a three-dimensional bone implant adapted for implantation to a patient, implants produced by such a method, and uses of such implants. The method comprises disposing differentiated osteoblasts on a matrix support comprising at least one of collagen, calcium phosphate, calcium sulfate and tricalcium phosphate; contacting the differentiated osteoblasts on the matrix with autologous blood serum from the patient, comprising at least one of a growth factor and a cytokine; and disposing the differentiated osteoblasts on the matrix support and the medium in a bioreactor, in which production of the bone implant is performed.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: February 23, 2016
    Assignee: SHELTAGEN MEDICAL LTD.
    Inventor: Orit Rosenberg
  • Bioavailable minerals for plant health
    Patent number: 9266785
    Abstract: A method employing a composition of bioavailable minerals directed at supplementing nutritional intake of a living plant. The composition includes the ionic mineral(s) copper and zinc in a ligand complex and a pharmaceutically acceptable carrier including water, H2SO4 and (NH4)2SO4. The composition for use in the method may also include other supporting plant nutrients such as botanical extracts, urea, plant hormones, vitamins and mineral supplements necessary for plant health.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: February 23, 2016
    Assignee: Zero Gravity Solutions, Inc.
    Inventor: John Wayne Kennedy
  • Deacetylase inhibitor therapy
    Patent number: 9259452
    Abstract: The present invention relates to deacetylase inhibitor (e.g., histone deacetylase inhibitor) therapies and demonstrates that individuals with low electrolyte levels may have increased susceptibility to certain unwanted side effects such as cardiac side effects. In some embodiments, the invention provides methods of administering DAC or DAC inhibitor therapy that includes electrolyte supplementation.
    Type: Grant
    Filed: January 6, 2015
    Date of Patent: February 16, 2016
    Assignees: Gelgene Corporation, The United States of America Department of Health and Human Services
    Inventors: William McCulloch, Richard L. Piekarz, Susan E. Bates
  • Cancer therapy via selective uptake of specialized nanoparticles in cancer cells
    Patent number: 9259468
    Abstract: Disclosed herein are polymer/fullerene nanoparticles that have selective uptake into cancer cells, and which, upon being taken into the cancer cells induce apoptosis. Induction of apoptosis can be controlled by activation of the nanoparticles. Activation can occur such as by photoactivation, or other means.
    Type: Grant
    Filed: October 9, 2012
    Date of Patent: February 16, 2016
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Andre Gesguiere, Mona Mathew, Zhongjian Hu
  • Dryable adhesive coating
    Patent number: 9260641
    Abstract: A dried adhesive coating is manufactured by steps of: a) providing a composition comprising a solution of a polymer, wherein at least 1 wt % of said polymer based on the molecular weight Mw are catechol groups, and wherein the concentration of said polymer in said composition is from 0.1 to 250 mg/ml, b) adjusting the pH of the composition to a value from about รณ to about 7, either (i) before applying the composition to the surface to be coated or (ii) after applying the composition to the surface to be coated, c) applying the composition to the surface to be coated to obtain an adhesive coating on at least a part of the surface, and d) drying the coating.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: February 16, 2016
    Assignee: Biopolymer Products of Sweden AB
    Inventor: Camilla Fant
  • Fungicide active substance combinations
    Patent number: 9253982
    Abstract: The novel active compound combinations comprising 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione of the formula and the active compound of groups (1) to (24) listed in the description have very good fungicidal properties.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: February 9, 2016
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Stefan Dutzmann, Klaus Stenzel, Manfred Jautelat
  • Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic
    Patent number: 9255336
    Abstract: An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: February 9, 2016
    Inventors: Verdis Norton, Gary L. Samuelson
  • Mesh based fluid delivery prosthesis and method of use
    Patent number: 9248012
    Abstract: A fluid delivery system is used for the treatment of subcutaneous hernia sites and includes a bioabsorbable polymer fabric mesh layer and a bioabsorbable and permeable bladder attached to the upper side of the fabric mesh layer. Fluid from the bladder is diffused through pores communicating between the bladder and the fabric mesh layer so as to be dispersed to underlying tissue.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: February 2, 2016
    Inventor: Jeremy J. Heffner
  • Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds
    Patent number: 9248149
    Abstract: The invention features methods and selenium-containing compositions for treating a neoplastic disease in a subject. In particular, the invention features methods for enhancing sensitivity of a tumor to cancer therapy by treating the tumor with an inorganic selenium-containing (iSe) compound and with a cancer therapy, particularly a cancer therapy that also affects the cellular redox status of a tumor cell (e.g., radiation).
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: February 2, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Susan J. Knox, Bryan Husbeck
  • Anticoagulant antagonist and hemophilia procoagulant
    Patent number: 9241958
    Abstract: A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: January 26, 2016
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Stephanie A. Smith, James H. Morrissey
  • Functional cellulosic moldings
    Patent number: 9243349
    Abstract: The invention relates to cellulosic moldings having very finely distributed zinc pigments after the dry-wet extrusion method. Cellulosic moldings formed in accordance with the inventive methods, compared to unmodified cellulose fibers, have a high degree of whiteness combined with greatly increased UV light absorption and a wash-resistant bactericidal effect, while at the same time having unrestricted textile processability. The cellulosic functional moldings produced according to the invention are particularly suited for use in textiles for clothing, technical textiles, recreation, medicine, and cosmetics.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: January 26, 2016
    Assignee: smartpolymer GmbH
    Inventors: Axel Kolbe, Hardy Markwitz
  • Compositions, methods and kits for therapeutic treatment with wet spun microstructures
    Patent number: 9238011
    Abstract: Methods, compositions, systems, devices and kits are provided for preparing and using a multi-layer polymeric microstructure composition for delivering a therapeutic agent to a subject. In various embodiments, the therapeutic agent includes at least one selected from the group of: a drug, a protein, a sugar, a carbohydrate, and a nucleotide sequence. In related embodiments, the composition is a fiber, a suture, a sphere, an implant, or a scaffold.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 19, 2016
    Assignee: Brown University
    Inventors: Edith Mathiowitz, Danya Lavin, Richard Hopkins
  • Tamper resistant solid oral dosage forms
    Patent number: 9233073
    Abstract: Disclosed in certain embodiments is a solid oral dosage form comprising: (a) an inert tamper resistant core; and (b) a coating surrounding the core, the coating comprising an active agent.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: January 12, 2016
    Assignee: Purdue Pharma L.P.
    Inventor: Richard S. Sackler
  • Synergistic paraffinic oil and boscalid fungicides
    Patent number: 9226504
    Abstract: Fungicidal compositions comprising a paraffinic oil and 2-chloro-N-(4?-chloro[1,1?-biphenyl]-2-yl)-3-pyridinecarboxamide (boscalid) are provided. The fungicidal compositions may further comprise a pigment. The fungicidal compositions may be provided as oil-in-water (O/W) emulsions which may be used for controlling fungal disease, such as dollar spot or bentgrass dead spot or bermudagrass dead spot, in plants, such as turfgrasses. Methods of applying the fungicidal compositions are also provided.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: January 5, 2016
    Assignee: Suncor Energy Inc.
    Inventors: Michael Fefer, Jun Liu
  • Method for inducing in vivo migration of stem cell
    Patent number: 9220757
    Abstract: The present invention relates to an implantable composition for treating a damaged tissue and a method for inducing an in vivo migration of a cell for treatment to a damaged tissue region. The present invention treats the damaged tissue by inducing/promoting homing of a cell for tissue generation by implanting a biodegradable scaffold reacted with chemotactic factors (for example, IL-8 or MIP-3?) to a damaged location (for example, joint cartilage or skin). Thus, the composition of the present invention can not only be applied to the treatment of a damaged bone tissue, a joint cartilage, or a skin tissue more conveniently and efficiently compared to the conventional technology, but can also be used as a useful treatment supplement agent in cell treatment using allogeneic cell by enabling efficient utilization of cell resources for treatment, the cell resources which are high in scarcity.
    Type: Grant
    Filed: January 26, 2012
    Date of Patent: December 29, 2015
    Assignee: Tego Science Inc.
    Inventors: Jin Woo Lee, Min Sung Park, Yun Hee Kim
  • Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
    Patent number: 9220820
    Abstract: Coatings for medical devices, methods of making the coatings, and methods of using them are described.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: December 29, 2015
    Inventors: Keith M. Faucher, Hui Tang, Lisa Rogers, Joseph Ferraro, Paul Martakos, Steven A. Herweck, Theodore Karwoski
  • All natural body powder that balances your PH and eliminates, bacteria, fungus, microbes and any body odor, including odor passed onto articles of clothing or shoes
    Patent number: 9220739
    Abstract: An all-natural, multi-purpose body powder comprised of Boric Acid, Organic Lavender, Tea Tree, Eucalyptus and Peppermint. The ratios of Boric Acid to Organic Lavender and Tea Tree are 288:1. The ratios of Boric Acid to Organic Eucalyptus and Peppermint are 1728:1. All of said ingredients create an environment that bacteria cannot grow in, wherein body, foot and shoe odor is prevented.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: December 29, 2015
    Inventor: Shaun Hunter
  • Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
    Patent number: 9220782
    Abstract: The present invention relates to a long-acting sustained-release dosage form for treatment of Parkinson Disease, comprising a dopamine receptor agonist and a pharmaceutically acceptable biodegradable polymer accessories, wherein the content of the dopamine receptor agonist in the sustained-release dosage form is 5-50% by weight, and the content of the pharmaceutically acceptable polymer accessories is 50-95% by weight.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: December 29, 2015
    Assignee: Shandong Luye Pharmaceutical Co., Ltd.
    Inventor: Luping Zhang